Skip to main content
. 2022 Sep 7;57(1):86–99. doi: 10.1007/s43441-022-00442-9

Table 3.

Efficacy and safety of therapeutic applications

Efficacy Safety
Efficacy endpoint Treatment duration Long-term efficacy after treatment Safety endpoint
reSET Abstinence at 9–12 weeks and retention in outpatient therapy 12 Weeks Not prescribed
reSET-O Longest continuous abstinence, total abstinence, and days in retained in the treatment at 12 weeks 12 Weeks Not prescribe
Somryst Patient health questionnaire at 6 months 9 Weeks 18 Month Not prescribe
EndeavorRx Change in the test of variables of attention–attention performance index at 4 weeks 4 Weeks 1 Month Not prescribed
NightWare Pittsburgh Sleep Quality Index Scale at 30 days 30 Days Epworth Sleepiness Scale and Columbia Suicide Severity Rating Scale
Parallel IBS Symptom Severity Score and Work and Social Adjustment Scale at 12 months 12 Weeks 9 Month Not prescribed
The CureApp smoking cessation system Continuous abstinence rate from weeks 9–24 24 Weeks 6 Month Not prescribed